Company Update (NYSE:MDT): Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker Now Available in Europe

[Thomson Reuters ONE] – New Device Automatically Adapts to Patient Needs, Continuously Optimizes Therapy, Improves Response Rate and Reduces Heart Failure Hospitalizations MINNEAPOLIS, MAY 1, 2014 – Medtronic, Inc. (NYSE:MDT) … Read more . . . → Read More: Company Update (NYSE:MDT): Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker Now Available in Europe Similar Articles: Company Update: Medtronic Inc (NYSE:MDT) – Medtronic Sutureless Heart Valve First to Show Five-Year Safety and Efficacy Outcomes Medtronic Inc (NYSE:MDT) – Medtronic CoreValve® System Demonstrates Long-Term Durability Market Update (NYSE:MDT): First Patients Enrolled in Medtronic Clinical Study Designed to Identify Patients at High Risk for Sudden Cardiac Arrest in Developing Countries